• Coronado Biosciences Inc., of Burlington, Mass., filed a registration statement with the SEC for a public offering of 2 million shares of common stock. Oppenheimer & Co. Inc. and Roth Capital Partners are acting as joint book-running managers.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter